News
XFG is part of the Omicron family, of which there are now more than 1,000 known subvariants, but it’s rising rapidly in ...
A 33-year-old Chinese man from Shanghai has been arrested in Italy on allegations of industrial espionage connected to a US ...
The compatibility of technologies is critical to the commercialization of advanced therapies in the biotechnology industry.
Hosted on MSN27d
Sarepta Viral Vector Gets FDA Platform Technology Designation
The rAAVrh74 viral vector is a key component in several of Sarepta’s gene therapy programs, including Elevidys, an already FDA-approved gene therapy for Duchenne muscular dystrophy.
In the accompanying study, we showed the functional importance of interaction between X and the host protein UVDDB-p127, in the transactivation and apoptotic properties of the viral protein.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results